|
显示项目 536376-536400 / 2307932 (共92318页)
<< < 21451 21452 21453 21454 21455 21456 21457 21458 21459 21460 > >>
每页显示[10|25|50]项目
| 中國醫藥大學 |
2003 |
Laparoscopy-assisted vaginal hysterectomy clinical pathway - A multivariate analysis of impact on costs and quality of care
|
Chang, WC; Lee, CC; Wu, HC; Yeh, LS |
| 中國醫藥大學 |
2003 |
Laparoscopy-assisted vaginal hysterectomy clinical pathway - A multivariate analysis of impact on costs and quality of care
|
Chang, WC; Lee, CC; Wu, HC; Yeh, LS |
| 中國醫藥大學 |
2003 |
Laparoscopy-assisted vaginal hysterectomy clinical pathway: a multivariate analysis of impact on costs and quality of care.
|
張維君(Chang,Wei-Chun); 李建忠; 吳錫金(Wu,His-Chin); 葉聯舜(Yen,Lian-Shung) |
| 臺北醫學大學 |
2007 |
Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis.
|
曾啟瑞; Jeng CJ; Huang SH; Shen J; Chou CS; Tzeng CR |
| 臺北醫學大學 |
2007 |
Laparoscopy-Guided Myometrial Biopsy in the Definite Diagnosis of Diffuse Adenomyosis.
|
鄭丞傑; Jeng CJ; Huang SH; Shen J; Chou CS; Tzeng CR |
| 臺北醫學大學 |
2014 |
Lapatinib and platinum-based chemotherapy ameliorate breast cancer with choroidal metastasis and restore visual acuity
|
Ju, UH;Tsai, ML;Lin, CS;Chao, TY;Dai, MS |
| 義守大學 |
2015-11 |
Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
|
Yu-Chun Hsiao;Ming-Hsin Yeh;Yun-Ju Chen;Ju-Fang Liu;Chih-Hsin Tang;Wei-Chien Huang |
| 中國醫藥大學 |
2015-09 |
Lapatinib increases motility of triple-negative breast cancer cells by decreasing MiRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
|
(Yu-Jun Hsiao);(Ming-Hsin Yeh);Yun-Ju Chen;Ju fang Liu;湯智昕(Tang Chih-Hsin);黃偉謙(Wei-Chien Huang)* |
| 義守大學 |
2016-07 |
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
|
Yu-Jen Chen;Li-Wen Fang;Wen-Chi Su;Wen-Yi Hsu;Kai-Chien Yang;Huey-Lan Huang |
| 臺大學術典藏 |
2021-05-07T06:48:00Z |
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
|
Chen Y.-J.; Fang L.-W.; Su W.-C.; Hsu W.-Y.; KAI-CHIEN YANG; Huang H.-L. |
| 臺北醫學大學 |
2014 |
Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
|
YJ, Chen;CW, Chi;WC, Su;HL, Huang |
| 臺北醫學大學 |
2014 |
Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
|
Chen, YJ;Chi, CW;Su, WC;Huang, HL |
| 中國醫藥大學 |
2014-05 |
Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
|
(Yu-Jen Chen);(Chih-Wen Chi);蘇文琪(Wen-Chi Su);黃惠蘭(Huey-Lan Huang)* |
| 中國醫藥大學 |
2014-05 |
Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma
|
(Yu-Jen Chen);(Chih-Wen Chi);蘇文琪(Wen-Chi Su);黃惠蘭(Huey-Lan Huang)* |
| 中國醫藥大學 |
2011-12 |
Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells
|
(Huey-Lan Huang);(Yu-Chieh Chen);黃毓銓(Yu-Chuen Huang);(Kai-Chien Yang);(Hsin yi Pan);(Shou-Ping Shih);陳裕仁(Yu-Jen Chen)* |
| 臺大學術典藏 |
2021-05-07T06:48:04Z |
Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells
|
Huang H.-L.; Chen Y.-C.; Huang Y.-C.; KAI-CHIEN YANG; Pan H.y.; Shih S.-P.; Chen Y.-J. |
| 中國醫藥大學 |
2014-05-27 |
Lapatinib induces IL-6 expression via MAPK pathway in triple-negative breast cancer cells
|
蕭宇君(Hsiao Yu-Chun);陳孟良(Mong-Liang Chen);陳韻如(Chen Yun-Ju);湯智昕(Tang Chih-Hsin);黃偉謙(Wei-Chien Huang)* |
| 臺大學術典藏 |
2018-09-10T14:52:06Z |
Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study
|
KUN-HUEI YEH; Satoh, T. and Doi, T. and Ohtsu, A. and Tsuji, A. and Omuro, Y. and Mukaiyama, A. and Kobayashi, M. and Miwa, H. and Xu, R.-H. and Sun, G.-P. and Xu, J.-M. and Wang, J.-W. and Li, J. and Qin, S.-K. and Feng, J.-F. and Chung, H.C. and Bang, Y.-J. and Chung, I.-J. and Yeh, K.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study
|
Satoh T.;Doi T.;Ohtsu A.;Tsuji A.;Omuro Y.;Mukaiyama A.;Kobayashi M.;Miwa H.;Xu R.-H.;Sun G.-P.;Xu J.-M.;Wang J.-W.;Li J.;Qin S.-K.;Feng J.-F.;Chung H.C.;Bang Y.-J.;Chung I.-J.;Kun-Huei Yeh; Satoh T.; Doi T.; Ohtsu A.; Tsuji A.; Omuro Y.; Mukaiyama A.; Kobayashi M.; Miwa H.; Xu R.-H.; Sun G.-P.; Xu J.-M.; Wang J.-W.; Li J.; Qin S.-K.; Feng J.-F.; Chung H.C.; Bang Y.-J.; Chung I.-J.; KUN-HUEI YEH |
| 國立成功大學 |
2012-02-18 |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
|
Baselga, Jose; Bradbury, Ian; Eidtmann, Holger; Di Cosimo, Serena; de Azambuja, Evandro; Aura, Claudia; Gomez, Henry; Dinh, Phuong; Fauria, Karine; Van Dooren, Veerle; Aktan, Gursel; Goldhirsch, Aron; Chang, Tsai-Wang; Horvath, Zsolt; Coccia-Portugal, Maria; Domont, Julien; Tseng, Ling-Min; Kunz, Georg; Sohn, Joo Hyuk; Semiglazov, Vladimir; Lerzo, Guillermo; Palacova, Marketa; Probachai, Volodymyr; Pusztai, Lajos; Untch, Michael; Gelber, Richard D.; Piccart-Gebhart, Martine |
| 國立臺灣大學 |
2014 |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
de Azambuja, Evandro; Holmes, Andrew P.; Piccart-Gebhart, Martine; Holmes, Eileen; Di Cosimo, Serena; Swaby, Ramona F.; Untch, Michael; Jackisch, Christian; Lang, Istvan; Smith, Ian; Boyle, Frances; Xu, Binghe; Barrios, Carlos H.; Perez, Edith A.; Azim, Hatem A., Jr.; Kim, Sung-Bae; Kuemmel, Sherko; Huang, Chiun-Sheng; Vuylsteke, Peter; Hsieh, Ruey-Kuen; Gorbunova, Vera; Eniu, Alexandru; Dreosti, Lydia; Tavartkiladze, Natalia; Gelber, Richard D.; Eidtmann, Holger; Baselga, Jose; 黃俊升 |
| 臺大學術典藏 |
2018-09-10T15:02:13Z |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
de Azambuja, E. and Holmes, A.P. and Piccart-Gebhart, M. and Holmes, E. and Di Cosimo, S. and Swaby, R.F. and Untch, M. and Jackisch, C. and Lang, I. and Smith, I. and Boyle, F. and Xu, B. and Barrios, C.H. and Perez, E.A. and Azim, H.A. and Kim, S.-B. and Kuemmel, S. and Huang, C.-S. and Vuylsteke, P. and Hsieh, R.-K. and Gorbunova, V. and Eniu, A. and Dreosti, L. and Tavartkiladze, N. and Gelber, R.D. and Eidtmann, H. and Baselga, J.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-23T07:19:13Z |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
Xu B.; Boyle F.; Smith I.; Jackisch C.; Lang I.; Untch M.; Swaby R.F.; Di Cosimo S.; Holmes E.; Piccart-Gebhart M.; Holmes A.P.; De Azambuja E.;Holmes A.P.;Piccart-Gebhart M.;Holmes E.;Di Cosimo S.;Swaby R.F.;Untch M.;Jackisch C.;Lang I.;Smith I.;Boyle F.;Xu B.;Barrios C.H.;Perez E.A.;Azim H.A.;Kim S.-B.;Kuemmel S.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.-K.;Gorbunova V.;Eniu A.;Dreosti L.;Tavartkiladze N.;Gelber R.D.;Eidtmann H.;Baselga J.; De Azambuja E.; Barrios C.H.; Perez E.A.; Azim H.A.; Kim S.-B.; Kuemmel S.; CHIUN-SHENG HUANG; Vuylsteke P.; Hsieh R.-K.; Gorbunova V.; Eniu A.; Dreosti L.; Tavartkiladze N.; Gelber R.D.; Eidtmann H.; Baselga J. |
| 中國醫藥大學 |
2013-12-31 |
Lapatinib 脫靶效應增強HDAC抑制劑對三陰性乳癌治療效果之探討
|
葉名焮(Ming-Hsin, Alex, Yeh);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2013-11 |
Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
|
(Yun-Ju Chen);葉名焮(Ming-Hsin, Alex, Yeh);游孟潔(Meng-Chieh Yu);魏雅鈴(Ya-Ling Wei);(Wen-Shu Chen);(Jhen-Yu Chen);(Chih-Yu Shih);涂智彥(Chih-Yen Tu);陳家弘(Chia-Hung Chen);夏德椿(Te-Chun Hsia);(Pei-Hsuan Chien);(Shu-Hui Liu);余永倫(Yung-Luen Yu);黃偉謙(Wei-Chien Huang)* |
显示项目 536376-536400 / 2307932 (共92318页)
<< < 21451 21452 21453 21454 21455 21456 21457 21458 21459 21460 > >>
每页显示[10|25|50]项目
|
